CASE REPORT
Rapidly progressive, large nascent cervical myoma with intrauterine device – case report and review of literature
More details
Hide details
1
Department of Perinatology and Gynecological-Obstetrical Nursing, Institute of Nursing and Obstetrics, Faculty of Medicine and Health
Science, Jan Kochanowski University, Kielce, Poland
Submission date: 2016-11-12
Final revision date: 2017-01-08
Acceptance date: 2017-02-20
Publication date: 2017-03-31
Medical Studies 2017;33(1):51-54
KEYWORDS
TOPICS
ABSTRACT
This report presents the case of a 38-year-old woman with an uncomplicated intrauterine device in the uterine cavity diagnosed with a rapidly progressing, nascent myoma of cervical origin, finally managed by abdominal hysterectomy. The observation is unique due to the demonstration of a rapid tumour growth pace in a 2-year interval, documented by transvaginal ultrasound scans, evolution of its vascularisation with a consistent high resistance index measured by spectral Doppler, unusual (cervical) primary location with no myometrial cells shedding during the aspiration biopsy, nascent character behaviour while being non-pedunculated, coexistence with an intrauterine device, and the approach to definite clinical management after failure of the attempt to perform a vaginal myomectomy. The study points out obstacles in obtaining reassurance of a benign character of rapidly progressing tumours of mesenchymal origin before surgery.
REFERENCES (10)
1.
Farquhar CM, Steiner CA. Hysterectomy rates in the United States 1990-1997. Obstet Gynecol 2002; 99: 229-34.
2.
Rice KE, Secrist JR, Woodrow EL, Hallock LM, Neal JL. Etiology, diagnosis, and management of uterine leiomyomas. J Midwifery Women’s Health 2012; 57: 241-7.
3.
Zimmermann A, Bernuit D, Gerlinger C, Schaefers M, Geppert K. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC Women’s Health 2012; 12: 6.
4.
Laughlin SK, Baird DD, Savitz DA, Herring AH, Hartmann KE. Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study. Obstet Gynecol 2009; 113: 630-5.
5.
Sabry M, Al-Hendy A. Medical treatment of uterine leiomyoma. Reprod Sci 2012; 19: 339-53.
6.
Golan A, Zachalka N, Lurie S, Sagiv R, Glezerman M. Vaginal removal of prolapsed pedunculated submucous myoma: a short, simple, and definitive procedure with minimal morbidity. Arch Gynecol Obstet 2005; 271: 11-3.
7.
Terzic M, Maricic S, Dotlic J. Vaginal removal of very large nascent uterine myoma – case report and literature review. Geburtshilfe Frauenheilkd 2013; 73: 724-6.
8.
Aviram R, Ochshorn Y, Markovitch O, Fishman A, Cohen I, Altaras MM, Tepper R. Uterine sarcomas versus leiomyomas: gray-scale and Doppler sonographic findings. J Clin Ultrasound 2005; 33: 10-3.
9.
Nagai T, Takai Y, Akahori T, Ishida H, Hanaoka T, Uotani T, Sato S, Matsunaga S, Baba K, Seki H. Novel uterine sarcoma preoperative diagnosis score predicts the need for surgery in patients presenting with a uterine mass. Springerplus 2014; 3: 678.
10.
Oda K, Okada S, Nei T, Shirai T, Takahashi M, Sano Y, Shiromizu K. Cytodiagnostic problems in uterine sarcoma. Analysis according to a novel classification of tumor growth types. Acta Cytol 2004; 48: 181-6.